Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

555 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Current therapy for medulloblastoma.
Gottardo NG, Gajjar A. Gottardo NG, et al. Among authors: gajjar a. Curr Treat Options Neurol. 2006 Jul;8(4):319-34. doi: 10.1007/s11940-006-0022-x. Curr Treat Options Neurol. 2006. PMID: 16942675
Chemotherapy of medulloblastoma.
Gajjar A, Kühl J, Epelman S, Bailey C, Allen J. Gajjar A, et al. Childs Nerv Syst. 1999 Oct;15(10):554-62. doi: 10.1007/s003810050543. Childs Nerv Syst. 1999. PMID: 10550586 Review.
Neurocognitive deficits in medulloblastoma survivors and white matter loss.
Mulhern RK, Reddick WE, Palmer SL, Glass JO, Elkin TD, Kun LE, Taylor J, Langston J, Gajjar A. Mulhern RK, et al. Among authors: gajjar a. Ann Neurol. 1999 Dec;46(6):834-41. doi: 10.1002/1531-8249(199912)46:6<834::aid-ana5>3.0.co;2-m. Ann Neurol. 1999. PMID: 10589535
Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma.
Mulhern RK, Palmer SL, Merchant TE, Wallace D, Kocak M, Brouwers P, Krull K, Chintagumpala M, Stargatt R, Ashley DM, Tyc VL, Kun L, Boyett J, Gajjar A. Mulhern RK, et al. Among authors: gajjar a. J Clin Oncol. 2005 Aug 20;23(24):5511-9. doi: 10.1200/JCO.2005.00.703. J Clin Oncol. 2005. PMID: 16110011
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.
Gajjar A, Chintagumpala M, Ashley D, Kellie S, Kun LE, Merchant TE, Woo S, Wheeler G, Ahern V, Krasin MJ, Fouladi M, Broniscer A, Krance R, Hale GA, Stewart CF, Dauser R, Sanford RA, Fuller C, Lau C, Boyett JM, Wallace D, Gilbertson RJ. Gajjar A, et al. Lancet Oncol. 2006 Oct;7(10):813-20. doi: 10.1016/S1470-2045(06)70867-1. Lancet Oncol. 2006. PMID: 17012043 Clinical Trial.
M1 Medulloblastoma: high risk at any age.
Sanders RP, Onar A, Boyett JM, Broniscer A, Morris EB, Qaddoumi I, Armstrong GT, Boop FA, Sanford RA, Kun LE, Merchant TE, Gajjar A. Sanders RP, et al. Among authors: gajjar a. J Neurooncol. 2008 Dec;90(3):351-5. doi: 10.1007/s11060-008-9671-9. Epub 2008 Aug 15. J Neurooncol. 2008. PMID: 18704266 Free PMC article.
Chemotherapy for malignant brain tumors of childhood.
Gottardo NG, Gajjar A. Gottardo NG, et al. Among authors: gajjar a. J Child Neurol. 2008 Oct;23(10):1149-59. doi: 10.1177/0883073808321765. J Child Neurol. 2008. PMID: 18952581 Free PMC article. Review.
555 results